TipRanks
Advertisement
Advertisement
Tenax Therapeutics downgraded to Neutral from Buy at Guggenheim
PremiumThe FlyTenax Therapeutics downgraded to Neutral from Buy at Guggenheim
22d ago
Tenax Therapeutics announces results from Phase 3 LEVEL trial of TNX-103
Premium
The Fly
Tenax Therapeutics announces results from Phase 3 LEVEL trial of TNX-103
23d ago
Tenax Therapeutics downgraded to Neutral from Buy at Chardan
Premium
The Fly
Tenax Therapeutics downgraded to Neutral from Buy at Chardan
1M ago
Tenax Therapeutics downgraded to Market Perform from Outperform at William Blair
PremiumThe FlyTenax Therapeutics downgraded to Market Perform from Outperform at William Blair
1M ago
Tenax Therapeutics price target lowered to $5 from $30 at Roth Capital
Premium
The Fly
Tenax Therapeutics price target lowered to $5 from $30 at Roth Capital
1M ago
Tenax sinks 87% to $1.69 after hypertension study failure
Premium
The Fly
Tenax sinks 87% to $1.69 after hypertension study failure
1M ago
Tenax Therapeutics reports Q2 EPS (35c), consensus (36c)
PremiumThe FlyTenax Therapeutics reports Q2 EPS (35c), consensus (36c)
2M ago
Tenax Therapeutics initiated with a Buy at Canaccord
Premium
The Fly
Tenax Therapeutics initiated with a Buy at Canaccord
2M ago
Tenax Therapeutics initiated with a Buy at Canaccord
Premium
The Fly
Tenax Therapeutics initiated with a Buy at Canaccord
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100